Pardridge W M, Eisenberg J, Yang J
Metabolism. 1987 Sep;36(9):892-5. doi: 10.1016/0026-0495(87)90099-0.
The kinetics of binding and endocytosis of 125I-human holotransferrin by isolated human brain capillaries was examined using this system as a model of the human blood-brain barrier (BBB). Both binding and endocytosis of the peptide by human brain capillaries was temperature-dependent and the binding was saturated by holotransferrin, but not by insulin, somatostatin, or vasopressin. Scatchard analysis of the binding reaction revealed a dissociation constant of 448 +/- 110 ng/mL (5.6 +/- 1.4 nmol/L) and a maximal binding constant (Ro) of 8.0 +/- 1.5 ng/mg protein. Thus, the affinity and capacity of the BBB transferrin receptor is within the same order of magnitude as the affinity and capacity of the BBB receptors for insulin, insulinlike growth factor-I, or insulinlike growth factor-II. The human brain capillary transferrin receptor was also detected with a mouse monoclonal antibody to the receptor using the avidin/biotin/peroxidase technique. In conclusion, these studies characterize the human BBB transferrin receptor and support the hypothesis that this receptor acts as a transport system which mediates the transcytosis of transferrin-bound iron through the brain capillary endothelial cell in man.
利用该系统作为人类血脑屏障(BBB)的模型,研究了分离的人脑毛细血管对¹²⁵I-人全转铁蛋白的结合和内吞动力学。人脑毛细血管对该肽的结合和内吞均依赖于温度,且全转铁蛋白可使结合饱和,但胰岛素、生长抑素或血管加压素则不能。对结合反应进行Scatchard分析,结果显示解离常数为448±110 ng/mL(5.6±1.4 nmol/L),最大结合常数(Ro)为8.0±1.5 ng/mg蛋白。因此,血脑屏障转铁蛋白受体的亲和力和容量与血脑屏障对胰岛素、胰岛素样生长因子-I或胰岛素样生长因子-II受体的亲和力和容量处于同一数量级。还使用抗生物素蛋白/生物素/过氧化物酶技术,用针对该受体的小鼠单克隆抗体检测了人脑毛细血管转铁蛋白受体。总之,这些研究对人类血脑屏障转铁蛋白受体进行了表征,并支持了这样一种假说,即该受体作为一种转运系统,介导转铁蛋白结合的铁通过人脑毛细血管内皮细胞进行转胞吞作用。